All In Biotech

Drug Trial Radar · NCT00785291

Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer

A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound Nab-paclitaxel or Ixabepilone With or Without Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer

Last checked: Nov 19, 2026Latest source record: Jun 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 799 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

799

Actual

Start

Oct 13, 2008

Primary completion

Dec 31, 2013

Study completion Jun 15, 2017

Sponsor

Sponsor type
NIH
First posted
Nov 5, 2008

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized phase III trial studies the side effects and how well different chemotherapy regimens with or without bevacizumab work in treating patients with stage IIIC or stage IV breast cancer. Drugs used in chemotherapy, such as paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel), and ixabepilone, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may block tumor growth by targeting certain cells and slowing the growth of blood vessels to the tumor. It is not yet known which treatment regimen is more effective in treating patients with breast cancer.

Conditions

  • Estrogen Receptor Negative
  • Estrogen Receptor Positive
  • HER2/Neu Negative
  • HER2/Neu Positive
  • Progesterone Receptor Negative
  • Progesterone Receptor Positive
  • Recurrent Breast Carcinoma
  • Stage IIIC Breast Cancer AJCC v6
  • Stage IV Breast Cancer AJCC v6 and v7

Interventions

  • BevacizumabBiological

    Given IV

  • IxabepiloneDrug

    Given IV

  • Laboratory Biomarker AnalysisOther

    Correlative studies

  • Nab-paclitaxelDrug

    Given IV

  • PaclitaxelDrug

    Given IV

  • Questionnaire AdministrationOther

    Ancillary studies

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression Free SurvivalTime frame: Time from randomization to progression or death due to any cause, whichever occurs first (up to 5 years)

Locations

704 sites in 2 countries. Site status is shown where the registry gives one.

  • Mayo Clinic in Arizona

    Scottsdale, Arizona

  • Sparks Regional Medical Center

    Fort Smith, Arkansas

  • Mercy Hospital Fort Smith

    Fort Smith, Arkansas

  • NEA Baptist Memorial Hospital

    Jonesboro, Arkansas

  • Kaiser Permanente-Anaheim

    Anaheim, California

  • Kaiser Permanente-Deer Valley Medical Center

    Antioch, California

  • PCR Oncology

    Arroyo Grande, California

  • Kaiser Permanente-Baldwin Park

    Baldwin Park, California

  • Kaiser Permanente-Bellflower

    Bellflower, California

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California

  • Providence Saint Joseph Medical Center/Disney Family Cancer Center

    Burbank, California

  • Mills-Peninsula Medical Center

    Burlingame, California

  • East Bay Radiation Oncology Center

    Castro Valley, California

  • Eden Hospital Medical Center

    Castro Valley, California

  • Valley Medical Oncology Consultants-Castro Valley

    Castro Valley, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Bay Area Breast Surgeons Inc

    Emeryville, California

  • Kaiser Permanente-Fontana

    Fontana, California

  • Kaiser Permanente-Fremont

    Fremont, California

  • Valley Medical Oncology Consultants-Fremont

    Fremont, California

  • Kaiser Permanente-Fresno

    Fresno, California

  • Marin Cancer Care Inc

    Greenbrae, California

  • Marin General Hospital

    Greenbrae, California

  • Kaiser Permanente - Harbor City

    Harbor City, California

  • Kaiser Permanente-Irvine

    Irvine, California

  • Loma Linda University Medical Center

    Loma Linda, California

  • Kaiser Permanente Los Angeles Medical Center

    Los Angeles, California

  • Kaiser Permanente West Los Angeles

    Los Angeles, California

  • Contra Costa Regional Medical Center

    Martinez, California

  • El Camino Hospital

    Mountain View, California

  • Sutter Cancer Research Consortium

    Novato, California

  • Highland General Hospital

    Oakland, California

  • Alta Bates Summit Medical Center - Summit Campus

    Oakland, California

  • Bay Area Tumor Institute

    Oakland, California

  • Hematology and Oncology Associates-Oakland

    Oakland, California

  • Tom K Lee Inc

    Oakland, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • Kaiser Permanente - Panorama City

    Panorama City, California

  • Valley Care Health System - Pleasanton

    Pleasanton, California

  • Valley Medical Oncology Consultants

    Pleasanton, California

Showing 40 of 704 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.